Same-day ablation and WATCHMAN closure for AFib
Part of Heart & circulation clinical trials.
This study tests whether doing a common AFib procedure (radiofrequency ablation) is safe and effective at the same time as closing off the left atrial appendage with the WATCHMAN FLX device. It's for people with nonvalvular atrial fibrillation who are already candidates for both treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have nonvalvular atrial fibrillation (AFib, an irregular heartbeat that is not caused by a heart valve problem)
- Your doctor plans to use the WATCHMAN FLX device to close off a small pouch in your heart (the left atrial appendage) to reduce stroke risk
- Before the procedure, imaging shows the shape of that pouch is right for the device
- You do not have other serious health problems like recent major bleeding, blood clots, or kidney/liver failure
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial combines two procedures at once: a pulsed field ablation to treat atrial fibrillation and a device implant to close the left atrial appendage to reduce stroke risk. It is designed for people in Asia who need both treatments and may benefit from having them together.
This study tests if adding a special energy treatment (pulsed field ablation) to a standard heart pouch closure is safe and works better for people with persistent atrial fibrillation who have few symptoms but a high risk of stroke.
This trial is for people who need both a special heart treatment called pulsed field ablation (FARAPULSE) and a device to close off a small pouch in the heart (WATCHMAN FLX Pro or WATCHMAN FLX) to prevent strokes. The study will see how well both procedures work when done together.
This study tracks people with atrial fibrillation (an irregular heartbeat) who get the WATCHMAN FLX Pro device to reduce stroke risk. It collects real-world data on how well the device works and how safe it is.
This study tests whether combining a heart procedure (catheter ablation) with a device to close the left atrial appendage (LAAO) is safer or better than blood thinners alone for frail patients 75 years or older with atrial fibrillation and high stroke risk. It aims to find a treatment that reduces stroke while lowering bleeding risks.
This trial tests a new type of heart procedure called pulsed field ablation to treat an irregular heartbeat (atrial fibrillation) in people who have already had a device placed to close off a part of the heart (left atrial appendage occlusion). The goal is to see if this safer ablation method can help control your heart rhythm.
Hear when a new Cardiovascular Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.